News | August 27, 2024
Mangalam Drugs & Organics awarded US$ 274,800 grant by MMV
The grant is designated for the research and development of Pyronaridine
The grant is designated for the research and development of Pyronaridine
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
174 applications were received for 23 eligible products under Target Segment IV - Other Chemical Synthesis Based KSMs/ Drug Intermediates/APIs.
Subscribe To Our Newsletter & Stay Updated
